Lv61
2020 积分 2023-12-04 加入
Ipilimumab with atezolizumab-bevacizumab in patients with advanced hepatocellular carcinoma: The PRODIGE 81-FFCD 2101-TRIPLET-HCC trial
17天前
已完结
Efficacy of stereotactic ablative radiotherapy in patients with oligometastatic hepatocellular carcinoma: A phase II study
1个月前
已完结
Combination locoregional and systemic therapies in hepatocellular carcinoma
1个月前
已完结
存活肿瘤细胞比例在初始不可切除肝细胞癌患者转化序贯外科治疗预后评估中的应用
3个月前
已完结
Response Evaluation Criteria in Cancer of the Liver (RECICL) proposed by the Liver Cancer Study Group of Japan (2009 Revised Version)
3个月前
已完结
肝细胞癌肝内转移与多中心发生的研究进展
3个月前
已完结
Perioperative tislelizumab plus neoadjuvant chemotherapy for patients with resectable non-small-cell lung cancer (RATIONALE-315): an interim analysis of a randomised clinical trial
4个月前
已完结
Randomized trial of anetumab ravtansine and pembrolizumab compared to pembrolizumab for mesothelioma
5个月前
已完结
Hepatocellular Carcinoma: A Phase II Randomized Controlled Double-Blind Trial of Transarterial Chemoembolization in Combination with Biweekly Intravenous Administration of Bevacizumab or a Placebo
5个月前
已完结
Transarterial Chemoembolization in Combination with a Molecular Targeted Agent: Lessons Learned from Negative Trials (Post-TACE, BRISK-TA, SPACE, ORIENTAL, and TACE-2)
5个月前
已完结
皖公网安备34019202002308
